Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
Clinical trial NCT07686770 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686770
- Sponsor
- Children's Hospital of Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.